Clinical Trial Update: A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating LEO 32731 with midazolam in healthy male subjects was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 32731
• Midazolam (Midazolam)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: TERMINATED